From professional translators, enterprises, web pages and freely available translation repositories.
natalitsumabi
natalizumab
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
tysabri natalitsumabi
tysabri natalizumab
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
natalitsumabi 627 609 589
609 589
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
vaikuttava aine on natalitsumabi.
the active substance is natalizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
natalitsumabi on suunniteltu sitoutumaan
natalizumab has been designed to bind to a specific part of an ‘ integrin ’ called ‘ 4 1 integrin’.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
sen vaikuttava aine on natalitsumabi.
it contains the active substance natalizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
natalitsumabi erittyy ihmisen rintamaitoon.
natalizumab is excreted in human milk.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
urosten hedelmällisyyteen natalitsumabi ei vaikuttanut.
reductions in female guinea pig fertility were observed in one study at doses in excess of the human dose; natalizumab did not affect male fertility.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
tysabri 300 mg infuusiokonsentraatti, liuosta varten natalitsumabi
tysabri 300 mg concentrate for solution for infusion natalizumab
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
lumelääke / natalitsumabi 300 mg laskimoon 4 viikon välein
placebo / natalizumab 300 mg i.v. every 4 weeks
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tysabrin vaikuttava aine natalitsumabi on monoklonaalinen vasta-aine.
the active substance in tysabri, natalizumab, is a monoclonal antibody.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
natalitsumabi saattaa hillitä sairaan kudoksen tulehdusaktiivisuutta ja estää immuunisolujen pääsyä tulehtuneisiin kudoksiin.
as such, natalizumab may act to suppress inflammatory activity present at the disease site, and inhibit further recruitment of immune cells into inflamed tissues.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
natalitsumabi on suunniteltu kiinnittymään erityiseen integriinin osaan, jota kutsutaan nimellä α4β1-integriini.
natalizumab has been designed to attach to a specific part of an ‘integrin’ called ‘α4β1 integrin’.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
natalitsumabi-hoidon jälkeen sinun on mahdollisesti odotettava 2-3 kuukautta ennen gilenyan aloittamista.
after stopping natalizumab you may have to wait for 2-3 months before starting treatment with gilenya.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tämä viittaa siihen, että natalitsumabi saattaa erittyä rintamaitoon myös ihmisellä (ks. kohta 4. 6).
6.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
natalitsumabi estää α4β7-integriinin interaktion limakalvon addressiinisolun adheesiomolekyyli 1:n (madcam-1) kanssa.
natalizumab blocks the interaction of α4β7 integrin with the mucosal addressin cell adhesion molecule-1 (madcam-1).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
yksi millilitra konsentraattia sisältää 20 mg natalitsumabia.
each ml of concentrate contains 20 mg of natalizumab.
Last Update: 2017-04-26
Usage Frequency: 4
Quality: